First Human Study of Ziftomenib for Treating Relapsed or Hard-to-Treat Acute Myeloid Leukemia | Clinical Trial

First Human Study of Ziftomenib for Treating Relapsed or Hard-to-Treat Acute Myeloid Leukemia | Clinical Trial | Right2Hope